FI95778C - Menetelmä taudinaiheuttajien inaktivoimiseksi biologisessa tai farmaseuttisessa aineessa - Google Patents

Menetelmä taudinaiheuttajien inaktivoimiseksi biologisessa tai farmaseuttisessa aineessa

Info

Publication number
FI95778C
FI95778C FI882387A FI882387A FI95778C FI 95778 C FI95778 C FI 95778C FI 882387 A FI882387 A FI 882387A FI 882387 A FI882387 A FI 882387A FI 95778 C FI95778 C FI 95778C
Authority
FI
Finland
Prior art keywords
biological
aqueous solution
pharmaceutical agent
inactivating pathogens
inactivating
Prior art date
Application number
FI882387A
Other languages
English (en)
Swedish (sv)
Other versions
FI95778B (fi
FI882387A0 (fi
FI882387A (fi
Inventor
Fred Feldman
Mark S Klekamp
Michael E Hrinda
Arthur B Shaw
Sudhish Chandra
Original Assignee
Armour Pharma Prod
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Armour Pharma Prod filed Critical Armour Pharma Prod
Publication of FI882387A0 publication Critical patent/FI882387A0/fi
Publication of FI882387A publication Critical patent/FI882387A/fi
Publication of FI95778B publication Critical patent/FI95778B/fi
Application granted granted Critical
Publication of FI95778C publication Critical patent/FI95778C/fi

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
    • A61L2/00—Methods or apparatus for disinfecting or sterilising materials or objects other than foodstuffs or contact lenses; Accessories therefor
    • A61L2/0005—Methods or apparatus for disinfecting or sterilising materials or objects other than foodstuffs or contact lenses; Accessories therefor for pharmaceuticals, biologicals or living parts
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
    • A61L2/00—Methods or apparatus for disinfecting or sterilising materials or objects other than foodstuffs or contact lenses; Accessories therefor
    • A61L2/0005—Methods or apparatus for disinfecting or sterilising materials or objects other than foodstuffs or contact lenses; Accessories therefor for pharmaceuticals, biologicals or living parts
    • A61L2/0011—Methods or apparatus for disinfecting or sterilising materials or objects other than foodstuffs or contact lenses; Accessories therefor for pharmaceuticals, biologicals or living parts using physical methods
    • A61L2/0023—Heat
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P7/00—Drugs for disorders of the blood or the extracellular fluid
    • A61P7/04—Antihaemorrhagics; Procoagulants; Haemostatic agents; Antifibrinolytic agents

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Chemical & Material Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Medicinal Chemistry (AREA)
  • Molecular Biology (AREA)
  • Biomedical Technology (AREA)
  • Epidemiology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Hematology (AREA)
  • Diabetes (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
  • Medicinal Preparation (AREA)
  • Agricultural Chemicals And Associated Chemicals (AREA)
FI882387A 1987-05-22 1988-05-20 Menetelmä taudinaiheuttajien inaktivoimiseksi biologisessa tai farmaseuttisessa aineessa FI95778C (fi)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US5292687A 1987-05-22 1987-05-22
US5292687 1987-05-22

Publications (4)

Publication Number Publication Date
FI882387A0 FI882387A0 (fi) 1988-05-20
FI882387A FI882387A (fi) 1988-11-23
FI95778B FI95778B (fi) 1995-12-15
FI95778C true FI95778C (fi) 1996-03-25

Family

ID=21980809

Family Applications (1)

Application Number Title Priority Date Filing Date
FI882387A FI95778C (fi) 1987-05-22 1988-05-20 Menetelmä taudinaiheuttajien inaktivoimiseksi biologisessa tai farmaseuttisessa aineessa

Country Status (11)

Country Link
EP (1) EP0292003B1 (fi)
JP (2) JP2605102B2 (fi)
AT (1) ATE103185T1 (fi)
AU (1) AU606159B2 (fi)
CA (1) CA1337688C (fi)
DE (1) DE3888571T2 (fi)
ES (1) ES2061554T3 (fi)
FI (1) FI95778C (fi)
IL (1) IL86417A (fi)
NO (1) NO176234C (fi)
NZ (1) NZ224740A (fi)

Families Citing this family (12)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE3619565A1 (de) * 1986-06-11 1987-12-17 Behringwerke Ag Verfahren zur herstellung einer pasteurisierten immunglobulinpraeparation
EP0440509A3 (en) * 1990-02-02 1991-12-18 Common Services Agency Novel cell growth medium components and process for producing same
AT402891B (de) * 1991-06-20 1997-09-25 Immuno Ag Verfahren zur herstellung eines inaktivierten blutproduktes
AT399818B (de) * 1992-04-24 1995-07-25 Immuno Ag Verfahren zur herstellung einer hochgereinigten virussicheren faktor viii-präparation
JP3133338B2 (ja) * 1992-12-16 2001-02-05 イムノ・アクチエンゲゼルシャフト ウイルス的に安全な生物学的組成物の調製方法
DE4320294A1 (de) * 1993-06-18 1994-12-22 Immuno Ag Verwendung von humanem Protein C zur Verhinderung und Behandlung von Thrombozytenablagerungen
HRP940645A2 (en) * 1993-10-06 1996-12-31 Immuno Ag Process for virus deactivation in the presence of polyalkylene glycol and the pharmaceutical preparation thus obtained
US5616693A (en) * 1996-07-01 1997-04-01 Alpha Therapeutic Corporation Process for seperating alpha-1-proteinase inhibitor from COHN IV1 +1V4 paste
DK2193809T3 (en) 1999-02-22 2015-05-26 Univ Connecticut The albumin-free Factor VIII formulation
KR20080019025A (ko) * 2005-06-06 2008-02-29 노보 노르디스크 에이/에스 안정화된 ｉｌ-21 조성물
DE102006008613A1 (de) 2006-02-24 2007-08-30 Dade Behring Marburg Gmbh Stabilisierte Zubereitungen von Serin-Endopeptidasen, deren Herstellung und Verwendung
MX339060B (es) 2008-11-07 2016-05-09 Baxter Int Formulaciones del factor viii.

Family Cites Families (15)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPS53142593A (en) * 1977-12-12 1978-12-12 Green Cross Corp:The Stabilization of urokinase by heating
DE3176491D1 (en) * 1980-03-05 1987-11-26 Miles Lab Pasteurized therapeutically active protein compositions
JPS56135418A (en) * 1980-03-27 1981-10-22 Green Cross Corp:The Heat treatment of aqueous solution containing 8 factor of coagulation of blood derived from human
DE3045153A1 (de) * 1980-11-29 1982-07-08 Behringwerke Ag, 3550 Marburg Verfahren zur herstellung von blutgerinnungsfaktoren und danach hergestellte praeparation der faktoren ix und x
JPS5874617A (ja) * 1981-10-28 1983-05-06 Green Cross Corp:The 人由来血液凝固第７因子含有水溶液の加熱処理方法
US4379085A (en) * 1982-05-14 1983-04-05 American National Red Cross Heat stabilization of plasma proteins
US4470968A (en) * 1983-01-13 1984-09-11 Miles Laboratories, Inc. Pasteurized therapeutically active blood coagulation factor concentrates
JPS59134730A (ja) * 1983-01-20 1984-08-02 Green Cross Corp:The 血液凝固第８因子の加熱処理法
CA1213827A (en) * 1983-04-29 1986-11-12 Ricardo H. Landaburu Process for pasteurizing fibronectin
JPH0669961B2 (ja) * 1984-09-25 1994-09-07 株式会社ミドリ十字 免疫グロブリンの加熱処理方法
JPS61189228A (ja) * 1985-02-19 1986-08-22 Nippon Sekijiyuujishiya 血液凝固第８因子製剤の製法
JPH0825902B2 (ja) * 1985-02-21 1996-03-13 株式会社ミドリ十字 γ−グロブリンの加熱処理方法
US4632980A (en) * 1985-04-03 1986-12-30 Immunologics Ozone decontamination of blood and blood products
JPS6289628A (ja) * 1985-09-11 1987-04-24 Green Cross Corp:The 人フイブリノゲン製剤の加熱処理法
JPS6281327A (ja) * 1985-10-04 1987-04-14 Green Cross Corp:The 人トロンビン製剤の加熱処理方法

Also Published As

Publication number Publication date
JPH09118634A (ja) 1997-05-06
NO176234C (no) 1995-03-01
AU606159B2 (en) 1991-01-31
FI95778B (fi) 1995-12-15
JP2879427B2 (ja) 1999-04-05
EP0292003B1 (en) 1994-03-23
DE3888571T2 (de) 1994-08-11
IL86417A (en) 1992-09-06
ES2061554T3 (es) 1994-12-16
AU1664288A (en) 1988-11-24
EP0292003A3 (en) 1990-06-13
DE3888571D1 (de) 1994-04-28
JPS649937A (en) 1989-01-13
NO176234B (no) 1994-11-21
IL86417A0 (en) 1988-11-15
NZ224740A (en) 1990-01-29
NO882242D0 (no) 1988-05-20
ATE103185T1 (de) 1994-04-15
CA1337688C (en) 1995-12-05
JP2605102B2 (ja) 1997-04-30
FI882387A0 (fi) 1988-05-20
FI882387A (fi) 1988-11-23
NO882242L (no) 1988-11-23
EP0292003A2 (en) 1988-11-23

Similar Documents

Publication Publication Date Title
FI95778C (fi) Menetelmä taudinaiheuttajien inaktivoimiseksi biologisessa tai farmaseuttisessa aineessa
ES8106407A1 (es) Procedimiento para el tratamiento de superficies hidrofobas
DE69032579D1 (de) Verwendung eines bakteriziden/die permeabilität erhöhenden proteins oder von biologisch aktiven analogen davon zur herstellung eines arzneimittels zur behandlung von endotoxin-assoziierten storungen
ATE235262T1 (de) Verfahren zum sterilisieren von produkten
HUT44793A (en) Process for production of 19-nor or 19-nor-d-homo stereoids substituated in position 11-beta by alkinylphenil group and medical preparatives containing them as active substance
LU84486A1 (fr) Nouveau derive de l'acide 2-(p-isobutylphenyl)propionique,son procede de preparation et son application en therapeutique
ES2065911T3 (es) Produccion de proteinas en formas activas.
DK162393C (da) Polysvovlsyreestere af bis-hexonsyreamider og derivater deraf samt fremgangsmaade til fremstilling af samme
SE8803071L (sv) Bakteriebehandling foer att bevara hoekvalitet genom att tillaegga genius bacillus mikroorganismer
FR2607517B2 (fr) Vecteurs d'expression de variants de l'hirudine dans les levures, procede et produit obtenu
PT90362A (pt) Metodo para o tratamento de doencas muco-epiteliais e da pele em mamiferos que utiliza acidos 4-quinolinocarboxilicos e seus derivados e processo para a preparacao de composicoes farmaceuticas que contem os mesmos compostos
CA2001448A1 (en) Method for sanitizing and improving the hatchability of hatchery eggs
PT86919A (pt) Method for using morpholine derivatives in medicine and agriculture and respective process of preparation
DE3779913D1 (de) Verdickte bleichmittel und verfahren zu deren herstellung.
PT79712B (fr) Procede de preparation de compositions nutritives contenant de l'acide alpha-cetoisocaproique ou un de ses sels et de medicaments les contenant
IT1230140B (it) Derivati della serina, loro processo di preparazione e impiego in terapia umana
NO920524L (no) Kynurensyrederivater, deres fremstilling og farmasoeytiskeblandinger inneholdende disse
ES524890A0 (es) Metodo de produccion de composiciones que contienen globulina gamma
ES2072331T3 (es) Procedimiento para la descontaminacion de cultivos celulares que contienen micoplasmas.
ATE48531T1 (de) Verfahren zum sterilisieren von rekombinantem mikroorganismus.
MA19398A1 (fr) Procede de preparation de thioalkylamide et de l'acide nicotinique, 1-oxyde et de ses sels
PT72567A (fr) Procede de preparation de derives du cycloheptindolol et de leurs sels avec les acides
UA13697A1 (uk) Спосіб передпосівhої обробки hасіhhя
FR2624524B1 (fr) Procede de traitement hydrometallurgique de solution de matieres galliferes
MA20183A1 (fr) Procede de valorisation de l'uranium,des terres rares et de l'ytterium contenus dans l'acide phosphorique

Legal Events

Date Code Title Description
GB Transfer or assigment of application

Owner name: ARMOUR PHARMACEUTICAL PRODUCTS, INC.

BB Publication of examined application
FG Patent granted

Owner name: ARMOUR PHARMACEUTICAL PRODUCTS, INC.

MA Patent expired